US 11135211
Pimavanserin for treating impulse control disorder
granted A61KA61K31/197A61K31/4468
Quick answer
US patent 11135211 (Pimavanserin for treating impulse control disorder) held by ACADIA Pharmaceuticals Inc. expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ACADIA Pharmaceuticals Inc.
- Grant date
- Tue Oct 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/197, A61K31/4468, A61P, A61P15/00